Seattle Genetics, Inc Receives $11,500,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fa9c7dd9-5198-499c-8707-2fe9578ecdda&Preview=1 -
Date
6/1/2009 -
Company Name
Seattle Genetics, Inc -
Mailing Address
21823 – 30th Drive S.E. Bothell, WA 98021 -
Company Description
Seattle Genetics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. Our strategy is to advance our portfolio of product candidates in diseases with unmet medical need and significant market potential. We have more than 250 employees and are located in a high-technology campus in Bothell, Washington, a suburb of Seattle. -
Website
http://www.seagen.com -
Transaction Type
Venture Equity -
Transaction Amount
$11,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Undisclosed
